Peptide Promo This Week – AAAMaxi.com https://www.aaamaxi.com The number 1 online site for hi-end performance enhancement and wellness products. Fully licensed offerings. Worldwide delivery. Fast safe and secure. Wed, 24 Jun 2026 12:09:49 +0000 en-US hourly 1 https://www.aaamaxi.com/wp-content/uploads/2026/03/site-icon-100x100.png Peptide Promo This Week – AAAMaxi.com https://www.aaamaxi.com 32 32 Genesis Peptides GHK-CU 100mg (10 bottles) https://www.aaamaxi.com/product/genesis-peptides-ghk-cu-100mg-10-bottles/ Mon, 29 Dec 2025 13:40:10 +0000 https://www.aaamaxi.com/?post_type=product&p=17666 GHK-Cu (Copper Peptide)

– Common Uses: Anti-aging, wound healing, skin repair.

– Dosage: 0.2 mL delivered subcutaneously. This is meant to be given once per day.

– Administration: Can be injected subcutaneously or used in topical skincare formulations.

– Duration: 4-6 weeks for noticeable results.

 

What Is GHK-Cu?

GHK-Cu, or copper peptide GHK-Cu, is a copper complex that occurs naturally in the human body. It is found in human plasma, saliva, and urine, where it forms a natural part of the way your body functions. In the body, it has an impact on a few different features. Though not all of this is known, there is evidence it is helpful in specific ways. These include boosting your immune system, healing wounds, providing antioxidants, working against inflammation, stimulating collagen, promoting the growth of blood vessels, and more. Essentially, GHK-Cu is just something that your body naturally creates and needs. With it, your body can run like it normally does. Without it, many of your body’s functions will not be as effective. The problem is that your levels of GHK are not always at an ideal level. The amount of GHK in a person generally decreases as they age. This causes problems, as not enough GHK is available to provide the health benefits it gives. So, your body ends up suffering from a lack of it, and many of the signs are similar to the general signs of aging. This is the main problem with GHK and is why people have more recently looked into other sources of it.

GHK-Cu Uses

The potential found within GHK is significant, yet the fact that it is lost over time creates a serious problem for many people. To address this, these same people seek to build GHK levels back up through products or peptide treatments that provide it. For people looking to take advantage of the health benefits of GHK-Cu, it is often provided through an injection. This provides the body with the GHK-Cu that it is already producing. This helps add to the effects or to raise GHK-Cu levels when they have dropped. GHK is also available in other forms. Specifically, it is often provided through topical foams and facial creams. These foams and creams focus on the ability of GHK-Cu to improve and restore skin. While creams and foams are effective in treating the skin, they do not have the deep-reaching effects provided by the GHK injection. However, they are easier to use. So, which option you choose will depend on what you are trying to achieve with GHK and how much you are willing to go through for it.

GHK-Cu Delivery Facts

GHK-Cu is delivered in different ways and different dosages depending on the form. Here are a few of the key facts about how it is delivered.

Dosage

GHK-Cu is available as a 10 mg/mL injection in a 5 mL vial. The injection is meant to be delivered subcutaneously. However, GHK-Cu is also available as a topical foam and facial cream. The foam is provided in 5 mg/mL (0.05%) doses and is designed to be applied to the scalp. The facial cream is given in the same 5 mg/mL (0.05%) doses.

Suggested Dosage

The injectable GHK-Cu suggested dosage is 0.2 mL delivered subcutaneously. This is meant to be given once per day.

Benefits of GHK-Cu

There are several different benefits provided by GHK-Cu. However, the exact nature of these benefits will depend on how it is applied. Older woman jogging in a park 

Benefits of GHK-Cu Injection

The GHK-Cu injection is one of the main ways to provide your body with GHK-Cu. This is important because, as you age, your body produces less and less of this helpful material. So, providing your body with it through an injection helps reverse this process. This makes GHK treatment similar to vitamin D treatment, as both simply seek to raise the levels of a material that your body needs. When used in this way, GHK has the potential to provide many of the benefits that your body’s natural GHK already provides. These include helping with wound healing and skin repair. It can also assist with the breakdown of collagen and glycosaminoglycans. GHK can go on to do some truly remarkable things with significant health impacts. Some studies have shown that it even has the potential to improve tissue repair and fight against cancer.

]]> Genesis Peptides KLOW 80 (BPC-157, TB-500, KPV, GHK-Cu) – 10 bottles https://www.aaamaxi.com/product/genesis-peptides-bpc-157-tb-500-kpv-ghk-cu-80mg-klow-blend/ Sat, 13 Dec 2025 05:54:58 +0000 https://www.aaamaxi.com/?post_type=product&p=17609 peptide blend or stack that typically combines four distinct peptides: BPC-157, TB-500, KPV, and GHK-Cu. This combination is designed to work synergistically to support healing, recovery, and overall wellness.]]> KLOW 80 – GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg)

1 pack = 10 bottles. Each bottle has 80mg of KLOW blend peptide. 99.8% pure made in our own licensed factory.

Absolute guarantee this product is 99.8% purity. Made in our own licensed factory and this is why we can bring this product to you at this price. Google it and see what other sites charge!  Guaranteed worldwide delivery with special channel shippers. Whether personal use or re seller, we can crush the price of any other seller. We have our own factory and that’s how. 

Klow” (also known as the Radiance Recovery Blend or Klow Blend) is a specific, popular formulation in the field of peptide therapy. It is a combination of four different peptides intended to promote recovery, reduce inflammation, and support overall cellular regeneration and wellness.

What the Klow Blend Contains
The blend combines the following four peptides, each with a specific role: 
  • BPC-157: A “Body Protective Compound” that supports the healing of soft tissues, including muscles, tendons, ligaments, and the gut lining.
  • TB-500: A synthetic peptide fragment of thymosin beta-4 that enhances cell migration, blood vessel formation, and systemic tissue repair.
  • GHK-Cu: A copper-binding peptide that stimulates collagen and elastin production, improving skin and hair quality and aiding in wound healing.
  • KPV: An immunomodulatory and anti-inflammatory tripeptide that helps manage the immune response and reduce inflammation, particularly in the gut.
Potential Benefits
When used in combination, the Klow blend is promoted for a range of benefits: 
  • Accelerated recovery from injuries, procedures, and workouts.
  • Reduced pain and inflammation.
  • Improved skin quality, hair growth, and anti-aging effects.
  • Enhanced gut health and immune system balance.
  • Increased energy and vitality.

The BPC157, TB500 (43 amino acid Thymosin Beta-4), KPV, and GHK-Cu quad blend combines four well-studied peptides that work through different but complementary pathways. BPC157 has been researched for supporting faster tissue healing, new blood vessel growth, and protection of the stomach and gut lining. TB500, the full 43aa Thymosin Beta-4 peptide, helps regulate actin, a key protein for cell movement and repair, and plays an important role in wound healing and tissue regeneration. KPV, a short fragment of alpha-MSH, is known for its anti-inflammatory and antimicrobial effects, mainly by reducing overactive immune signaling. GHK-Cu is a natural copper-binding peptide that stimulates collagen production, skin and hair regeneration, and cellular repair. Together, these four peptides may act synergistically—BPC157 and Thymosin Beta-4 strengthen repair and blood flow, KPV calms inflammation, and GHK-Cu drives tissue remodeling and renewal—making this blend a broad research platform for studying healing and regeneration.

 

Important Considerations
  • Medical Consultation Required: Peptides are powerful compounds, and their use requires consultation with a healthcare professional to ensure safety, determine appropriate dosage, and monitor potential side effects, such as injection site reactions, headaches, or fatigue.
  • Not a Sole Solution: The Klow blend is often positioned as a powerful tool to complement a healthy lifestyle including diet, hydration, and exercise, rather than a standalone “magic fix”.
  • Regulatory Status: While research is ongoing and promising, many peptides are still in clinical trials and are not always approved by regulatory bodies for general use. Sourcing from a trusted, medical professional is crucial. 

Dosing & Reconstitution Guide

This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~26.7 mg/mL total concentration.
  • Component concentrations: TB-500, BPC-157, KPV each at ~3.33 mg/mL; GHK-Cu at ~16.7 mg/mL.
  • Easy measuring: At 26.7 mg/mL total, 1 unit = 0.01 mL ≈ 267 mcg total peptide on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Standard / Gradual Approach (3 mL = ~26.7 mg/mL Total)

This multi-peptide blend provides synergistic regenerative, anti-inflammatory, and tissue-repair support. The following titration schedule allows gradual introduction of each component.

Week Daily Dose (per component) Units (per injection) (mL)
Weeks 1–2 TB-500: 250 mcg | BPC-157: 250 mcg | KPV: 250 mcg | GHK-Cu: 1.25 mg 7.5 units (0.075 mL)
Weeks 3–4 TB-500: 500 mcg | BPC-157: 500 mcg | KPV: 500 mcg | GHK-Cu: 2.5 mg 15 units (0.15 mL)
Weeks 5–8 TB-500: 750 mcg | BPC-157: 750 mcg | KPV: 750 mcg | GHK-Cu: 3.75 mg 22.5 units (0.225 mL)
Weeks 9–12 (Maintenance) TB-500: 500 mcg | BPC-157: 500 mcg | KPV: 500 mcg | GHK-Cu: 2.5 mg 15 units (0.15 mL)

Frequency: Inject once daily subcutaneously. This schedule uses a 3.0 mL dilution to maintain measurable volumes. For ≤10-unit (≤0.10 mL) administrations during initial weeks, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Syringe Math Reference

With 3.0 mL reconstitution volume and 80 mg total peptide:

  • Total concentration: 26.67 mg/mL (26,667 mcg/mL)
  • TB-500: 3.33 mg/mL → 33.3 mcg per unit
  • BPC-157: 3.33 mg/mL → 33.3 mcg per unit
  • KPV: 3.33 mg/mL → 33.3 mcg per unit
  • GHK-Cu: 16.67 mg/mL → 166.7 mcg per unit
  • 1 unit (0.01 mL) = 33.3 mcg each of TB-500, BPC-157, KPV + 166.7 mcg GHK-Cu

 

 

 

 

]]> Genesis Peptides GHK-CU 50mg (10 bottles) https://www.aaamaxi.com/product/ghk-cu-50mg-per-vial-10-vials-in-1-pack/ Tue, 08 Jul 2025 05:25:20 +0000 https://www.aaamaxi.com/?post_type=product&p=17064 GHK-Cu (Copper Peptide)

– Common Uses: Anti-aging, wound healing, skin repair.

– Dosage: 0.2 mL delivered subcutaneously. This is meant to be given once per day.

– Administration: Can be injected subcutaneously or used in topical skincare formulations.

– Duration: 4-6 weeks for noticeable results.

 

What Is GHK-Cu?

GHK-Cu, or copper peptide GHK-Cu, is a copper complex that occurs naturally in the human body. It is found in human plasma, saliva, and urine, where it forms a natural part of the way your body functions. In the body, it has an impact on a few different features. Though not all of this is known, there is evidence it is helpful in specific ways. These include boosting your immune system, healing wounds, providing antioxidants, working against inflammation, stimulating collagen, promoting the growth of blood vessels, and more. Essentially, GHK-Cu is just something that your body naturally creates and needs. With it, your body can run like it normally does. Without it, many of your body’s functions will not be as effective. The problem is that your levels of GHK are not always at an ideal level. The amount of GHK in a person generally decreases as they age. This causes problems, as not enough GHK is available to provide the health benefits it gives. So, your body ends up suffering from a lack of it, and many of the signs are similar to the general signs of aging. This is the main problem with GHK and is why people have more recently looked into other sources of it.

GHK-Cu Uses

The potential found within GHK is significant, yet the fact that it is lost over time creates a serious problem for many people. To address this, these same people seek to build GHK levels back up through products or peptide treatments that provide it. For people looking to take advantage of the health benefits of GHK-Cu, it is often provided through an injection. This provides the body with the GHK-Cu that it is already producing. This helps add to the effects or to raise GHK-Cu levels when they have dropped. GHK is also available in other forms. Specifically, it is often provided through topical foams and facial creams. These foams and creams focus on the ability of GHK-Cu to improve and restore skin. While creams and foams are effective in treating the skin, they do not have the deep-reaching effects provided by the GHK injection. However, they are easier to use. So, which option you choose will depend on what you are trying to achieve with GHK and how much you are willing to go through for it.

GHK-Cu Delivery Facts

GHK-Cu is delivered in different ways and different dosages depending on the form. Here are a few of the key facts about how it is delivered.

Dosage

GHK-Cu is available as a 10 mg/mL injection in a 5 mL vial. The injection is meant to be delivered subcutaneously. However, GHK-Cu is also available as a topical foam and facial cream. The foam is provided in 5 mg/mL (0.05%) doses and is designed to be applied to the scalp. The facial cream is given in the same 5 mg/mL (0.05%) doses.

Suggested Dosage

The injectable GHK-Cu suggested dosage is 0.2 mL delivered subcutaneously. This is meant to be given once per day.

Benefits of GHK-Cu

There are several different benefits provided by GHK-Cu. However, the exact nature of these benefits will depend on how it is applied. Older woman jogging in a park 

Benefits of GHK-Cu Injection

The GHK-Cu injection is one of the main ways to provide your body with GHK-Cu. This is important because, as you age, your body produces less and less of this helpful material. So, providing your body with it through an injection helps reverse this process. This makes GHK treatment similar to vitamin D treatment, as both simply seek to raise the levels of a material that your body needs. When used in this way, GHK has the potential to provide many of the benefits that your body’s natural GHK already provides. These include helping with wound healing and skin repair. It can also assist with the breakdown of collagen and glycosaminoglycans. GHK can go on to do some truly remarkable things with significant health impacts. Some studies have shown that it even has the potential to improve tissue repair and fight against cancer.

]]> Genesis Peptides BPC157 (5mg) +TB500 5mg blend (10 bottles) https://www.aaamaxi.com/product/bpc157-5mg-super-human-recovery-peptide-tb500-5mg-mixed/ Thu, 22 May 2025 05:44:03 +0000 https://www.aaamaxi.com/?post_type=product&p=16848 aaamaxi.com TB500 & BPC157 Peptide Stack combines 5 mg of BPC-157 and 5 mg of TB-500 in a single vial, offering a powerful blend designed to enhance tissue repair and reduce inflammation. This synergistic combination supports faster recovery from injuries, promotes digestive health, and improves flexibility and mobility. Ideal for athletes and individuals seeking overall well-being, this stack leverages the regenerative properties of both peptides to boost the body’s natural healing processes.

This product ships from USA warehouse and also from our China warehouse

]]> Genesis Peptides BPC157 10mg Super Human Recovery peptide (10 bottles) https://www.aaamaxi.com/product/bpc157-10mg-super-human-recovery-peptide/ Mon, 14 Oct 2024 02:09:55 +0000 https://www.aaamaxi.com/?post_type=product&p=15484 Detailed Breakdown of BPC-157 Benefits
Mechanisms of Action
BPC-157 stimulates angiogenesis, the formation of new blood vessels, which enhances nutrient and blood delivery to damaged tissues. This peptide also boosts collagen production, essential for tissue repair, and reduces inflammation, which collectively accelerate healing .

Specific Benefits and Conditions

1) Soft Tissue Injuries:
Bursitis and Tendinitis: BPC-157 has shown effectiveness in reducing inflammation and promoting tissue repair, which can alleviate pain and improve function in conditions like bursitis and tendinitis .

Ligament Injuries: Studies in rats demonstrated that BPC-157 enhances ligament healing, making it useful for treating ligament sprains and tears

2) Joint Pain and Cartilage Damage:
Arthritis (Osteoarthritis and Rheumatoid Arthritis): While direct human studies on arthritis are limited, BPC-157’s ability to promote collagen production and reduce inflammation suggests potential benefits for managing arthritis symptoms .

Chondromalacia Patella: This condition involves the softening of the cartilage under the kneecap. BPC-157’s role in collagen synthesis and cartilage repair could help manage symptoms and promote healing .

3) Muscle Pain and Recovery:
Muscle Tears and Chronic Muscle Pain: BPC-157 promotes muscle healing through enhanced angiogenesis and nutrient delivery, which can benefit athletes and individuals recovering from muscle injuries.

4) Nerve Pain:
Neuropathy and Nerve Injuries: BPC-157 has potential in promoting nerve regeneration, observed in studies on spinal cord injuries, indicating benefits for conditions involving nerve damage (16).

Sciatica: This condition is caused by irritation or compression of the sciatic nerve. BPC-157’s anti-inflammatory and nerve-regenerative properties might help alleviate symptoms and promote nerve healing (16).

5) Bone Healing:
Fractures and Osteoporosis: BPC-157 has shown significant potential in promoting bone healing and regeneration in animal studies, suggesting it could be useful for treating fractures and improving bone density (8, 23).

6) Spinal Disc Injuries:
Herniated Discs and Degenerative Disc Disease: While specific studies on spinal discs are limited, BPC-157’s tissue healing properties and ability to promote collagen production suggest potential benefits for disc injuries (1, 16).

7) Gut Health:
Inflammatory Bowel Diseases (IBD): BPC-157 has effectively reduced inflammatory markers and promoted healing in conditions like ulcerative colitis and Crohn’s disease, helping restore gut integrity and function .

8) Wound Healing and Skin Repair:
Chronic Wounds and Surgical Recovery: By enhancing collagen production and angiogenesis, BPC-157 accelerates wound healing and skin repair, making it beneficial for chronic wounds and post-surgical recovery .

9) Organ Protection:
Liver and Kidney Health: BPC-157 protects against drug-induced damage to the liver and kidneys, highlighting its potential in safeguarding these vital organs
Cardiovascular Health: Studies indicate that BPC-157 can reduce myocardial infarction damage and improve heart function, suggesting cardiovascular protective effects .

10) Neuroprotection:
Brain Injuries and Neurological Conditions: BPC-157 shows potential in protecting and repairing brain tissue, beneficial in treating neurological conditions like multiple sclerosis and Parkinson’s disease .

Psychosocial Factors in Pain Management
Pain is influenced by psychological and social factors, alongside physical injury. Chronic pain can be exacerbated by stress, anxiety, and depression. While BPC-157 addresses the biological aspects of pain by reducing inflammation and promoting tissue repair, comprehensive pain management should also consider psychosocial factors to improve overall outcomes.

We sometimes hear about users saying BPC-157 did not work but we always ask them to review their individual lifestyle, and cognitive approach first before even considering using this or any other supplement for pain relief.

BPC-157 Side Effects
What are the side effects of BPC-157?
While BPC-157 is generally well-tolerated, potential side effects include:

Mild gastrointestinal issues if taken on an empty stomach
Changes in appetite or weight
Dizziness
Fatigue
Headaches

BPC-157 Dangers: Is it Actually Safe?
BPC-157 is considered safe for use, being naturally found in gastric juices (6). However, due to limited human clinical trials, long-term safety is not fully understood. It is recommended to discontinue use if any concerns arise. Notably, BPC-157 is not currently banned by the World Anti-Doping Agency, making it a viable option for athletes (12) although certain sports bodies do not permit its use so be sure to check.

BPC-157 Dosage Guidelines
The typical dosage for BPC-157 is 200mg to 500mg a day.

Frequently Asked Questions
Is BPC 157 a steroid?
No, BPC-157 is a peptide, not a steroid. It does not have anabolic or androgenic effects but aids in muscle and tissue repair.

Is it safe for men and women to take?
Yes, it has no hormonal effects of any kind and can be taken by men and women.

Is it safe for older individuals?
Yes, in fact it is probably more beneficial to older individuals.

Can BPC-157 treat pain from my injury?
BPC-157 improves the regeneration and repair of damaged tissue through multiple mechanisms. However, pain is not always related to tissue damage. In fact, even if two people had the exact same tissue damage, their degree of pain could range from none to severe. The psychosocial aspect of pain is poorly understood but pain is governed by far more than biological factors so when it comes to pain management you should first pay attention to understanding what that means. Here is a great thread we found from Layne Norton, a guy we interviewed over ten years ago whose interview is still well worth a read.

Does BPC-157 Build Muscle?
While BPC-157 does not directly build muscle, it can enhance recovery, allowing for more frequent and intense training sessions.

Should I take BPC-157 with food or not?
Yes, BPC-157 should be taken with food.

Can You Take BPC-157 Orally?
Yes, BPC-157 can be taken orally. Studies have shown that it remains effective and works systemically this way.

Should BPC-157 Be Taken with Food?
It is generally recommended to take BPC-157 with food to improve absorption and reduce potential gastrointestinal side effects.

How Long Does BPC-157 Take to Work?
Results can be seen in as little as 24-48 hours, depending on the severity of the injury. It is recommended to wait a week or two before adjusting the dosage if results are not immediate.

Is BPC-157 Systemic?
BPC-157 does not need to be injected at the site of injury.

Is BPC-157 Approved by the FDA?
BPC-157 is not approved by the FDA as a drug as it is considered experimental. However, it is legally available as a supplement.

]]> Genesis Peptides BPC157 5mg Super Human Recovery peptide (10 bottles) https://www.aaamaxi.com/product/bpc157-5mg-super-human-recovery-peptide/ Sat, 12 Oct 2024 06:44:27 +0000 https://www.aaamaxi.com/?post_type=product&p=15464 Detailed Breakdown of BPC-157 Benefits
Mechanisms of Action
BPC-157 stimulates angiogenesis, the formation of new blood vessels, which enhances nutrient and blood delivery to damaged tissues. This peptide also boosts collagen production, essential for tissue repair, and reduces inflammation, which collectively accelerate healing .

Specific Benefits and Conditions

1) Soft Tissue Injuries:
Bursitis and Tendinitis: BPC-157 has shown effectiveness in reducing inflammation and promoting tissue repair, which can alleviate pain and improve function in conditions like bursitis and tendinitis .

Ligament Injuries: Studies in rats demonstrated that BPC-157 enhances ligament healing, making it useful for treating ligament sprains and tears

2) Joint Pain and Cartilage Damage:
Arthritis (Osteoarthritis and Rheumatoid Arthritis): While direct human studies on arthritis are limited, BPC-157’s ability to promote collagen production and reduce inflammation suggests potential benefits for managing arthritis symptoms .

Chondromalacia Patella: This condition involves the softening of the cartilage under the kneecap. BPC-157’s role in collagen synthesis and cartilage repair could help manage symptoms and promote healing .

3) Muscle Pain and Recovery:
Muscle Tears and Chronic Muscle Pain: BPC-157 promotes muscle healing through enhanced angiogenesis and nutrient delivery, which can benefit athletes and individuals recovering from muscle injuries.

4) Nerve Pain:
Neuropathy and Nerve Injuries: BPC-157 has potential in promoting nerve regeneration, observed in studies on spinal cord injuries, indicating benefits for conditions involving nerve damage (16).

Sciatica: This condition is caused by irritation or compression of the sciatic nerve. BPC-157’s anti-inflammatory and nerve-regenerative properties might help alleviate symptoms and promote nerve healing (16).

5) Bone Healing:
Fractures and Osteoporosis: BPC-157 has shown significant potential in promoting bone healing and regeneration in animal studies, suggesting it could be useful for treating fractures and improving bone density (8, 23).

6) Spinal Disc Injuries:
Herniated Discs and Degenerative Disc Disease: While specific studies on spinal discs are limited, BPC-157’s tissue healing properties and ability to promote collagen production suggest potential benefits for disc injuries (1, 16).

7) Gut Health:
Inflammatory Bowel Diseases (IBD): BPC-157 has effectively reduced inflammatory markers and promoted healing in conditions like ulcerative colitis and Crohn’s disease, helping restore gut integrity and function .

8) Wound Healing and Skin Repair:
Chronic Wounds and Surgical Recovery: By enhancing collagen production and angiogenesis, BPC-157 accelerates wound healing and skin repair, making it beneficial for chronic wounds and post-surgical recovery .

9) Organ Protection:
Liver and Kidney Health: BPC-157 protects against drug-induced damage to the liver and kidneys, highlighting its potential in safeguarding these vital organs
Cardiovascular Health: Studies indicate that BPC-157 can reduce myocardial infarction damage and improve heart function, suggesting cardiovascular protective effects .

10) Neuroprotection:
Brain Injuries and Neurological Conditions: BPC-157 shows potential in protecting and repairing brain tissue, beneficial in treating neurological conditions like multiple sclerosis and Parkinson’s disease .

Psychosocial Factors in Pain Management
Pain is influenced by psychological and social factors, alongside physical injury. Chronic pain can be exacerbated by stress, anxiety, and depression. While BPC-157 addresses the biological aspects of pain by reducing inflammation and promoting tissue repair, comprehensive pain management should also consider psychosocial factors to improve overall outcomes.

We sometimes hear about users saying BPC-157 did not work but we always ask them to review their individual lifestyle, and cognitive approach first before even considering using this or any other supplement for pain relief.

BPC-157 Side Effects
What are the side effects of BPC-157?
While BPC-157 is generally well-tolerated, potential side effects include:

Mild gastrointestinal issues if taken on an empty stomach
Changes in appetite or weight
Dizziness
Fatigue
Headaches

BPC-157 Dangers: Is it Actually Safe?
BPC-157 is considered safe for use, being naturally found in gastric juices (6). However, due to limited human clinical trials, long-term safety is not fully understood. It is recommended to discontinue use if any concerns arise. Notably, BPC-157 is not currently banned by the World Anti-Doping Agency, making it a viable option for athletes (12) although certain sports bodies do not permit its use so be sure to check.

BPC-157 Dosage Guidelines
The typical dosage for BPC-157 is 200mg to 500mg a day.

Frequently Asked Questions
Is BPC 157 a steroid?
No, BPC-157 is a peptide, not a steroid. It does not have anabolic or androgenic effects but aids in muscle and tissue repair.

Is it safe for men and women to take?
Yes, it has no hormonal effects of any kind and can be taken by men and women.

Is it safe for older individuals?
Yes, in fact it is probably more beneficial to older individuals.

Can BPC-157 treat pain from my injury?
BPC-157 improves the regeneration and repair of damaged tissue through multiple mechanisms. However, pain is not always related to tissue damage. In fact, even if two people had the exact same tissue damage, their degree of pain could range from none to severe. The psychosocial aspect of pain is poorly understood but pain is governed by far more than biological factors so when it comes to pain management you should first pay attention to understanding what that means. Here is a great thread we found from Layne Norton, a guy we interviewed over ten years ago whose interview is still well worth a read.

Does BPC-157 Build Muscle?
While BPC-157 does not directly build muscle, it can enhance recovery, allowing for more frequent and intense training sessions.

Should I take BPC-157 with food or not?
Yes, BPC-157 should be taken with food.

Can You Take BPC-157 Orally?
Yes, BPC-157 can be taken orally. Studies have shown that it remains effective and works systemically this way.

Should BPC-157 Be Taken with Food?
It is generally recommended to take BPC-157 with food to improve absorption and reduce potential gastrointestinal side effects.

How Long Does BPC-157 Take to Work?
Results can be seen in as little as 24-48 hours, depending on the severity of the injury. It is recommended to wait a week or two before adjusting the dosage if results are not immediate.

Is BPC-157 Systemic?
BPC-157 does not need to be injected at the site of injury.

Is BPC-157 Approved by the FDA?
BPC-157 is not approved by the FDA as a drug as it is considered experimental. However, it is legally available as a supplement.

]]> R@ta 10mg (10 bottles) https://www.aaamaxi.com/product/reta-10mg-10-bottles-x-10mg/ Sun, 07 Apr 2024 05:11:52 +0000 https://www.aaamaxi.com/?post_type=product&p=14854
  • Aids in weight reduction
  • Improves blood glucose levels
  • Improves blood pressure
    • ]]>     Overall Health Benefits of R@ta

    R@ta is most commonly used for weight loss or diabetes. It may also improve blood pressure and quality of life.

    • Aids in weight reduction [1-7]
    • Improves blood glucose levels [2-7]
    • Improves blood pressure [5, 7]

    R@ta Key Takeaways

    • R@ta shows promise to be the best weight loss medication currently available including popular fat loss medications S@ma and and T@za.
    • R@ta was created to treat obesity and diabetes.
    • R@ta affects certain biological pathways related to metabolism, appetite regulation, and fat storage, leading to a reduction in body weight.
    • Clinical trials and studies have demonstrated that r@ta can result in significant weight loss when used as part of a comprehensive weight management program.
    • Apart from weight loss, R@ta may offer additional health benefits, such as improvements in insulin sensitivity, cardiovascular risk factors, and overall quality of life.
    • Before starting r@ta for treating obesity, consult with a healthcare professional. Regular monitoring, adherence to prescribed dosages, and healthy lifestyle adjustments are essential for achieving and maintaining the desired outcomes.

    What is R@ta?

    Reta, has a major potential for treating obesity and diabetes. Also known as GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943, this injectable medication is similar to existing weight loss medications like t@za and s@ma but has increased efficacy. When combined with proper diet, regular exercise, and lifestyle modifications, r@ta can help improve weight loss outcomes and treat comorbidities related to obesity such as diabetes or hypertension (high blood pressure).

    How R@ta Works?

    R@ta weight loss drug is more effective than other weight loss medications. It exerts its therapeutic effects through three important mechanisms:
    • Gastric inhibitory polypeptide receptor (GIPR) agonist: As a GIP receptor agonist, r@ta enhances appetite suppression and prevents fat accumulation, resulting in decreased energy intake and increased energy expenditure.
    • Glucagon-like peptide 1 receptor (GLP-1R) agonist: Reta reduces body weight by improving blood sugar levels via enhanced insulin release from the pancreas and reduced release of glucagon (a hormone that increases blood sugar).
    • Glucagon receptor (GR) agonist: Reta decreases glucagon release to improve blood sugar levels, decrease food intake, and increase energy expenditure which ultimately results in weight loss.

    Chemical Structure of R@ta

    A. Aids in Weight Reduction

    Aids in Weight Reduction

    Trial results show promising insights into the potential of r@ta for addressing obesity and various weight-related conditions:

    1. In a phase 2 trial published in the New England Journal of Medicine on June 26, 2023, 338 obese adults with a body mass index of 30 were enrolled. [1] The primary endpoint was the percentage change in body weight from baseline to 24 weeks. The secondary endpoint encompassed the percentage change in body weight from baseline to 48 weeks, as well as achieving weight reduction of 5% or more, 10% or more, or 15% or more. After 48 weeks, the groups who received a weekly injection of r@ta showed varying percentages of change in mean weight reduction: -8.7% for the 1-mg group, -17.1% for the combined 4-mg group, -22.8% for the combined 8-mg group, and -24.2% for the 12-mg group (highest dose), in contrast to -2.1% observed in the placebo group. Improvements in LDL-cholesterol, triglycerides, fasting glucose, insulin levels, total cholesterol, HbA1c, as well as systolic and diastolic blood pressure were also observed.
    2. In adults (aged 20-70 years) with type 2 diabetes for at least 3 months, the administration of r@ta at 3/6/9/12 mg resulted in robust reductions in body weight with an acceptable safety profile. After nine months, the participants also lost an average of 17% of their body weight. Combining glucagon receptor agonism with GIP and GLP-1 receptor agonism may be one of the reasons r@ta showed its potent weight loss effects. [2]
    3. In high-fat-fed mice, twice daily administration of r@ta for 21 days decreased body weight and nonfasting blood sugar levels and increased circulating insulin concentrations in the blood. [3]
    4. In mice with obesity, the administration of r@ta (LY3437943) decreased body weight, improved blood sugar control, and increased energy expenditure. [4]
    5. In forty-five healthy human subjects, the three highest doses of subcutaneous (under the skin) administration of r@ta produced a statistically significant weight loss that was maintained up to day 43. [5]
    6. In diet-induced obese mice, r@ta reduced appetite and body weight by 45% via reduced fat mass, making it superior to other GIPR and GLP-1R agonists. [6]

    7. In patients with type 2 diabetes (T2D) and obesity, subcutaneous administration of r@ta for 12 weeks resulted in reductions in body weight of up to 8.96 kg with a safety and tolerability profile similar to other incretins (weight loss peptides). [7]

    B. Improves Blood Sugar Levels

    Improves Blood Sugar Levels

    R@ta improves blood sugar levels through its effects on the hormones insulin and glucagon. Insulin lowers blood sugar levels while glucagon increases blood sugar levels to achieve homeostasis or balance. As a GLP-1 agonist and GR agonist, r@ta enhances insulin release from the pancreas while reducing glucagon release. This in turn helps achieve healthy blood sugar levels.

    Evidence from r@ta trials suggests that the medication can produce beneficial effects on the blood sugar levels of people with diabetes and uncontrolled blood sugar:

    1. In adults (aged 20-70 years) with T2D for at least 3 months, the administration of r@ta at 3/6/9/12 mg resulted in robust reductions in blood sugar levels with an acceptable safety profile compared with placebo treatment. [2]
    2. In high-fat-fed mice, twice daily administration of r@ta for 21 days decreased nonfasting blood sugar levels by increasing circulating insulin concentrations in the blood. [3]

    3. In obese mice, the administration of r@ta improved blood sugar control and increased energy expenditure which persisted up to day 43. [4]

    4. In forty-five healthy human subjects, the three highest doses of subcutaneous administration of r@ta resulted in increased mean fasting insulin and C-peptide, with maximum levels observed at 24 and 48 hours, which in turn lowered blood sugar levels. [5]
    5. In diet-induced obese mice, r@ta lowered blood sugar and insulin levels, indicating improved insulin sensitivity (the body’s response to the effects of insulin). [6]
    6. In patients with T2D, subcutaneous administration of r@ta for 12 weeks decreased glycated hemoglobin, also known as HbA1c and is a measure of blood sugar, with a higher safety and tolerability profile. [7]

    C. Improves Blood Pressure

    As a weight loss drug, r@ta can help improve blood pressure by treating obesity. By decreasing energy intake and increasing energy expenditure, r@ta can promote fat loss. Evidence suggests that weight loss is associated with blood pressure reduction. [8-10] This indicates that r@ta may be beneficial in people with hypertension.

    Studies support the blood pressure-lowering effects of r@ta:

    1. A Phase 1 r@ta clinical trial, which is the first human study assessing the safety and tolerability of single-ascending doses of @eta (LY3437943), included forty-five healthy subjects who were randomized to receive subcutaneous LY3437943 (6 rising dose levels) or placebo. [5] During the treatment period, important data such as vital signs, electrocardiogram (ECG), laboratory data, and adverse events were monitored. Fasting insulin, C-peptide, weight, and appetite were also measured. Results showed that the subjects who received r@ta had significant weight loss, increased insulin levels, and decreased systolic blood pressure (returned to near baseline by Day 29).
    2. A Phase 1 proof-of-concept study assessed the safety and tolerability of several ascending doses of r@ta in patients with T2D. [7] In this study, seventy-two diabetic patients were randomized to receive r@ta or placebo. During the treatment, the researchers assessed vital signs, laboratory data, and adverse events. After 12 weeks, the group that received r@ta had decreases in blood pressure with a higher safety and tolerability profile compared to the placebo group.

    Associated Side Effects of R@ta

    R@ta side effects are very uncommon. There have been some side effects associated with the use of this drug wherein the patient had one of the issues listed below at some point while being on r@ta. However, these side effects weren’t confirmed to be associated with the treatment and could have been a coincidence and not related to the use of r@ta. Despite this, it was listed as a side effect associated with r@ta even though these associated side effects are very uncommon.
    Side effects associated with r@ta may include the following:

    • Chest pain
    • Depression
    • Difficulty breathing
    • Dizziness
    • Dry mouth
    • Fatigue
    • Headache
    • Irregular heartbeat
    • Swelling in the hands and feet

    With regard to safety, the most common adverse events were related to the gastrointestinal system. These side effects are mild in nature and go away on their own. As a result, the safety and tolerability profile of r@ta aligns with other incretin-based therapies (hormones produced by the gut that help regulate blood sugar levels).

    R@ta Dosage

    R@ta is a new drug for obesity. The initial dose of r@ta is 0.5 mg, which is injected subcutaneously once weekly. The dose of the drug can be increased to 1 mg, 2 mg, or 4 mg after 4 weeks, depending on the patient’s response. The maximum dose is 12 mg per week.

    The initial dose of r@ta is important because it helps to minimize the risk of side effects. If the patient tolerates the initial dose well, the dose can be increased gradually. However, if the patient experiences any serious side effects, the dose of the drug should be reduced or discontinued.

    ]]>         R@ta 5mg (10 bottles) https://www.aaamaxi.com/product/reta-5mg-1-pack-10-bottles-x-5mg/ Sat, 25 Nov 2023 07:03:20 +0000 https://www.aaamaxi.com/?post_type=product&p=14537
  • Aids in weight reduction
  • Improves blood glucose levels
  • Improves blood pressure
    • ]]>     Overall Health Benefits of R@ta

    R@ta is most commonly used for weight loss or diabetes. It may also improve blood pressure and quality of life.

    • Aids in weight reduction [1-7]
    • Improves blood glucose levels [2-7]
    • Improves blood pressure [5, 7]

    R@ta Key Takeaways

    • R@ta shows promise to be the best weight loss medication currently available including popular fat loss medications S@ma and and T@za.
    • R@ta was created to treat obesity and diabetes.
    • R@ta affects certain biological pathways related to metabolism, appetite regulation, and fat storage, leading to a reduction in body weight.
    • Clinical trials and studies have demonstrated that r@ta can result in significant weight loss when used as part of a comprehensive weight management program.
    • Apart from weight loss, R@ta may offer additional health benefits, such as improvements in insulin sensitivity, cardiovascular risk factors, and overall quality of life.
    • Before starting r@ta for treating obesity, consult with a healthcare professional. Regular monitoring, adherence to prescribed dosages, and healthy lifestyle adjustments are essential for achieving and maintaining the desired outcomes.

    What is R@ta?

    Reta, has a major potential for treating obesity and diabetes. Also known as GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943, this injectable medication is similar to existing weight loss medications like t@za and s@ma but has increased efficacy. When combined with proper diet, regular exercise, and lifestyle modifications, r@ta can help improve weight loss outcomes and treat comorbidities related to obesity such as diabetes or hypertension (high blood pressure).

    How R@ta Works?

    R@ta weight loss drug is more effective than other weight loss medications. It exerts its therapeutic effects through three important mechanisms:
    • Gastric inhibitory polypeptide receptor (GIPR) agonist: As a GIP receptor agonist, r@ta enhances appetite suppression and prevents fat accumulation, resulting in decreased energy intake and increased energy expenditure.
    • Glucagon-like peptide 1 receptor (GLP-1R) agonist: Reta reduces body weight by improving blood sugar levels via enhanced insulin release from the pancreas and reduced release of glucagon (a hormone that increases blood sugar).
    • Glucagon receptor (GR) agonist: Reta decreases glucagon release to improve blood sugar levels, decrease food intake, and increase energy expenditure which ultimately results in weight loss.

    Chemical Structure of R@ta

    A. Aids in Weight Reduction

    Aids in Weight Reduction

    Trial results show promising insights into the potential of r@ta for addressing obesity and various weight-related conditions:

    1. In a phase 2 trial published in the New England Journal of Medicine on June 26, 2023, 338 obese adults with a body mass index of 30 were enrolled. [1] The primary endpoint was the percentage change in body weight from baseline to 24 weeks. The secondary endpoint encompassed the percentage change in body weight from baseline to 48 weeks, as well as achieving weight reduction of 5% or more, 10% or more, or 15% or more. After 48 weeks, the groups who received a weekly injection of r@ta showed varying percentages of change in mean weight reduction: -8.7% for the 1-mg group, -17.1% for the combined 4-mg group, -22.8% for the combined 8-mg group, and -24.2% for the 12-mg group (highest dose), in contrast to -2.1% observed in the placebo group. Improvements in LDL-cholesterol, triglycerides, fasting glucose, insulin levels, total cholesterol, HbA1c, as well as systolic and diastolic blood pressure were also observed.
    2. In adults (aged 20-70 years) with type 2 diabetes for at least 3 months, the administration of r@ta at 3/6/9/12 mg resulted in robust reductions in body weight with an acceptable safety profile. After nine months, the participants also lost an average of 17% of their body weight. Combining glucagon receptor agonism with GIP and GLP-1 receptor agonism may be one of the reasons r@ta showed its potent weight loss effects. [2]
    3. In high-fat-fed mice, twice daily administration of r@ta for 21 days decreased body weight and nonfasting blood sugar levels and increased circulating insulin concentrations in the blood. [3]
    4. In mice with obesity, the administration of r@ta (LY3437943) decreased body weight, improved blood sugar control, and increased energy expenditure. [4]
    5. In forty-five healthy human subjects, the three highest doses of subcutaneous (under the skin) administration of r@ta produced a statistically significant weight loss that was maintained up to day 43. [5]
    6. In diet-induced obese mice, r@ta reduced appetite and body weight by 45% via reduced fat mass, making it superior to other GIPR and GLP-1R agonists. [6]

    7. In patients with type 2 diabetes (T2D) and obesity, subcutaneous administration of r@ta for 12 weeks resulted in reductions in body weight of up to 8.96 kg with a safety and tolerability profile similar to other incretins (weight loss peptides). [7]

    B. Improves Blood Sugar Levels

    Improves Blood Sugar Levels

    R@ta improves blood sugar levels through its effects on the hormones insulin and glucagon. Insulin lowers blood sugar levels while glucagon increases blood sugar levels to achieve homeostasis or balance. As a GLP-1 agonist and GR agonist, r@ta enhances insulin release from the pancreas while reducing glucagon release. This in turn helps achieve healthy blood sugar levels.

    Evidence from r@ta trials suggests that the medication can produce beneficial effects on the blood sugar levels of people with diabetes and uncontrolled blood sugar:

    1. In adults (aged 20-70 years) with T2D for at least 3 months, the administration of r@ta at 3/6/9/12 mg resulted in robust reductions in blood sugar levels with an acceptable safety profile compared with placebo treatment. [2]
    2. In high-fat-fed mice, twice daily administration of r@ta for 21 days decreased nonfasting blood sugar levels by increasing circulating insulin concentrations in the blood. [3]

    3. In obese mice, the administration of r@ta improved blood sugar control and increased energy expenditure which persisted up to day 43. [4]

    4. In forty-five healthy human subjects, the three highest doses of subcutaneous administration of r@ta resulted in increased mean fasting insulin and C-peptide, with maximum levels observed at 24 and 48 hours, which in turn lowered blood sugar levels. [5]
    5. In diet-induced obese mice, r@ta lowered blood sugar and insulin levels, indicating improved insulin sensitivity (the body’s response to the effects of insulin). [6]
    6. In patients with T2D, subcutaneous administration of r@ta for 12 weeks decreased glycated hemoglobin, also known as HbA1c and is a measure of blood sugar, with a higher safety and tolerability profile. [7]

    C. Improves Blood Pressure

    As a weight loss drug, r@ta can help improve blood pressure by treating obesity. By decreasing energy intake and increasing energy expenditure, r@ta can promote fat loss. Evidence suggests that weight loss is associated with blood pressure reduction. [8-10] This indicates that r@ta may be beneficial in people with hypertension.

    Studies support the blood pressure-lowering effects of r@ta:

    1. A Phase 1 r@ta clinical trial, which is the first human study assessing the safety and tolerability of single-ascending doses of @eta (LY3437943), included forty-five healthy subjects who were randomized to receive subcutaneous LY3437943 (6 rising dose levels) or placebo. [5] During the treatment period, important data such as vital signs, electrocardiogram (ECG), laboratory data, and adverse events were monitored. Fasting insulin, C-peptide, weight, and appetite were also measured. Results showed that the subjects who received r@ta had significant weight loss, increased insulin levels, and decreased systolic blood pressure (returned to near baseline by Day 29).
    2. A Phase 1 proof-of-concept study assessed the safety and tolerability of several ascending doses of r@ta in patients with T2D. [7] In this study, seventy-two diabetic patients were randomized to receive r@ta or placebo. During the treatment, the researchers assessed vital signs, laboratory data, and adverse events. After 12 weeks, the group that received r@ta had decreases in blood pressure with a higher safety and tolerability profile compared to the placebo group.

    Associated Side Effects of R@ta

    R@ta side effects are very uncommon. There have been some side effects associated with the use of this drug wherein the patient had one of the issues listed below at some point while being on r@ta. However, these side effects weren’t confirmed to be associated with the treatment and could have been a coincidence and not related to the use of r@ta. Despite this, it was listed as a side effect associated with r@ta even though these associated side effects are very uncommon.
    Side effects associated with r@ta may include the following:

    • Chest pain
    • Depression
    • Difficulty breathing
    • Dizziness
    • Dry mouth
    • Fatigue
    • Headache
    • Irregular heartbeat
    • Swelling in the hands and feet

    With regard to safety, the most common adverse events were related to the gastrointestinal system. These side effects are mild in nature and go away on their own. As a result, the safety and tolerability profile of r@ta aligns with other incretin-based therapies (hormones produced by the gut that help regulate blood sugar levels).

    R@ta Dosage

    R@ta is a new drug for obesity. The initial dose of r@ta is 0.5 mg, which is injected subcutaneously once weekly. The dose of the drug can be increased to 1 mg, 2 mg, or 4 mg after 4 weeks, depending on the patient’s response. The maximum dose is 12 mg per week.

    The initial dose of r@ta is important because it helps to minimize the risk of side effects. If the patient tolerates the initial dose well, the dose can be increased gradually. However, if the patient experiences any serious side effects, the dose of the drug should be reduced or discontinued.

    ]]>